05:40 AM EDT, 05/07/2025 (MT Newswires) -- Novo Nordisk ( NVO ) reported Q1 earnings Wednesday of 6.53 Danish kroner ($0.99) per diluted share, up from 5.68 kroner a year earlier.

Analysts polled by FactSet expected 6.11 kroner.

Sales for the quarter ended March 31 were 78.09 billion kroner, up from 65.35 billion kroner a year earlier.

Analysts surveyed by FactSet expected 77.94 billion kroner.

For 2025, the pharmaceuticals giant lowered its sales growth projection to between 13% and 21%, down from its previous range of 16% to 24%.

It also lowered its expected operating profit growth to between 16% and 24%, down from a previous range of 19% to 27%.

Analysts polled by FactSet expect EPS of 26.47 kroner on revenue of 343.01 billion kroner.

Novo Nordisk ( NVO ) shares were up 7.5% in recent premarket activity.

Price: 71.15, Change: +4.95, Percent Change: +7.47